Psoriatic arthritis - change or recommencement authority application form (PB260)

Use this form to apply to change or recommence PBS-subsidised treatment with a biological medicine for adult patients with severe psoriatic arthritis.

Biological medicine refers to:

  • adalimumab
  • bimekizumab
  • certolizumab pegol
  • etanercept
  • golimumab
  • guselkumab
  • infliximab
  • ixekizumab
  • risankizumab
  • secukinumab
  • tofacitinib
  • upadacitinib
  • ustekinumab.

Please note: You don’t need to complete this form if you use the Online PBS Authorities system.

Download and complete the psoriatic arthritis - change or recommencement authority application form.

Page last updated: 1 July 2025.
QC 46911